Artivion's (NYSE:AORT) Q3 Sales Top Estimates [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
The company's full-year revenue guidance of $442 million at the midpoint came in 0.9% above analysts' estimates. Its non-GAAP profit of $0.16 per share was in line with analysts' consensus estimates. Is now the time to buy Artivion? Find out in our full research report Artivion (AORT) Q3 CY2025 Highlights: Revenue: $113.4 million vs analyst estimates of $110.5 million (18.4% year-on-year growth, 2.6% beat) Adjusted EPS: $0.16 vs analyst estimates of $0.15 (in line) Adjusted EBITDA: $24.57 million vs analyst estimates of $22.25 million (21.7% margin, 10.4% beat) The company slightly lifted its revenue guidance for the full year to $442 million at the midpoint from $439 million EBITDA guidance for the full year is $89.5 million at the midpoint, in line with analyst expectations Operating Margin: 11.1%, up from 4.6% in the same quarter last year Free Cash Flow Margin: 15.6%, up from 8.2% in the same quarter last year Market Capitalization: $2.19 billion "Our third q
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest [Yahoo! Finance]Yahoo! Finance
- Strong Q3 Results and Raised Outlook Could Be a Game Changer for Artivion (AORT) [Yahoo! Finance]Yahoo! Finance
- 2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges [Yahoo! Finance]Yahoo! Finance
- Artivion (AORT): Is the Healthcare Standout Fairly Valued After Recent Surge? [Yahoo! Finance]Yahoo! Finance
AORT
Earnings
- 11/6/25 - Beat
AORT
Sec Filings
- 12/4/25 - Form 4
- 12/4/25 - Form 4
- 12/3/25 - Form 4
- AORT's page on the SEC website